لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المصدر: Antiviral therapy. 19(7):625-636

مصطلحات موضوعية: IMMUNODEFICIENCY-VIRUS-INFECTION, ACUTE MYOCARDIAL-INFARCTION, TRIPLE-NUCLEOSIDE REGIMENS, PROTEASE INHIBITOR, DISOPROXIL FUMARATE COMBINATION, NAIVE HIV-1-INFECTED PATIENTS, HIV-INFECTED PATIENTS, COMBINATION ANTIRETROVIRAL THERAPY, ABACAVIR/LAMIVUDINE/ZIDOVUDINE PLUS TENOFOVIR, EARLY VIROLOGICAL FAILURE

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dris___01423::c2f1ea1082cb6caf3d7036ef530ecff8
https://research.rug.nl/en/publications/2166b882-8fbb-4535-85c7-57cc373d4d2e

المؤلفون: Wouter F W Bierman, Clemens Richter, Tjip S. van der Werf, Elisabeth H. Gisolf, Herman G. Sprenger

المصدر: Antiviral Therapy. 19:625-636

مصطلحات موضوعية: ACUTE MYOCARDIAL-INFARCTION, PROTEASE INHIBITOR, DISOPROXIL FUMARATE COMBINATION, Anti-HIV Agents, HIV Infections, HIV-INFECTED PATIENTS, Single class, Pharmacology, Maintenance Chemotherapy, TRIPLE-NUCLEOSIDE REGIMENS, Acquired immunodeficiency syndrome (AIDS), immune system diseases, Humans, Medicine, Pharmacology (medical), Protease inhibitor (pharmacology), Nucleotide, COMBINATION ANTIRETROVIRAL THERAPY, ABACAVIR/LAMIVUDINE/ZIDOVUDINE PLUS TENOFOVIR, Initial therapy, Randomized Controlled Trials as Topic, chemistry.chemical_classification, Acquired Immunodeficiency Syndrome, business.industry, Maintenance strategy, virus diseases, medicine.disease, Virology, Reverse transcriptase, IMMUNODEFICIENCY-VIRUS-INFECTION, Treatment Outcome, Infectious Diseases, NAIVE HIV-1-INFECTED PATIENTS, chemistry, Reverse Transcriptase Inhibitors, business, EARLY VIROLOGICAL FAILURE, Nucleoside

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8da4bbb11ed6fcb80fcb437ccb7a476
https://doi.org/10.3851/imp2726

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Axel Fun, Monique Nijhuis, Peter Messiaen, Nele Brusselaers, Linos Vandekerckhove, Annemarie M. J. Wensing

المصدر: PLoS ONE, Vol 8, Iss 1, p e52562 (2013)
PLOS ONE
PLoS ONE

مصطلحات موضوعية: Oncology, HEALTH-CARE PROGRAM, Epidemiology, Integrase inhibitor, lcsh:Medicine, HIV Infections, Pharmacology, TWICE-DAILY RALTEGRAVIR, law.invention, chemistry.chemical_compound, Randomized controlled trial, law, Medicine, lcsh:Science, CO-FORMULATED ELVITEGRAVIR, Clinical Trials as Topic, Multidisciplinary, LONG-TERM EFFICACY, Elvitegravir, HIV diagnosis and management, CROSS-RESISTANCE PROFILE, Viral Load, RANDOMIZED CONTROLLED-TRIAL, Antivirals, Treatment Outcome, Dolutegravir, Infectious diseases, Reverse Transcriptase Inhibitors, Drug Therapy, Combination, Research Article, medicine.drug, medicine.medical_specialty, Clinical Research Design, Viral diseases, Microbiology, Infectious Disease Epidemiology, Pharmacotherapy, Virology, Internal medicine, Drug Resistance, Viral, Humans, Protease Inhibitors, HIV Integrase Inhibitors, Adverse effect, Biology, OPTIMIZED BACKGROUND THERAPY, Population Biology, business.industry, lcsh:R, HIV, Biology and Life Sciences, NON-INFERIORITY TRIAL, Raltegravir, Regimen, TREATMENT-EXPERIENCED PATIENTS, NAIVE HIV-1-INFECTED PATIENTS, chemistry, HIV-1, lcsh:Q, Meta-Analyses, business, Viral Transmission and Infection

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::366b6a89ca7995de836e3971d4e343e8
http://europepmc.org/articles/PMC3541389?pdf=render

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.